Nonprostatic diseases on PSMA PET imaging: a spectrum of benign and malignant findings

PSMA PET imaging was originally used to assess biochemical recurrence of prostate cancer (PCa), but its clinical use was promptly extended to detection, staging and therapy response assessment. The expanding use of PSMA PET worldwide has also revealed PSMA ligand uptake in diverse nonprostatic disea...

Descripción completa

Detalles Bibliográficos
Autores principales: de Galiza Barbosa, Felipe, Queiroz, Marcelo Araujo, Nunes, Rafael Fernandes, Costa, Larissa Bastos, Zaniboni, Elaine Caroline, Marin, José Flavio Gomes, Cerri, Giovanni Guido, Buchpiguel, Carlos Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7071711/
https://www.ncbi.nlm.nih.gov/pubmed/32169115
http://dx.doi.org/10.1186/s40644-020-00300-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7071711/
https://www.ncbi.nlm.nih.gov/pubmed/32169115
http://dx.doi.org/10.1186/s40644-020-00300-7

Ejemplares similares